Beijing Cancer Hospital
Beijing,China
Recruiting CBP-1008-01
A multi-center, open-label, first-in-human, phase Ia and Ib study for evaluation of the safety, tolerability, and pharmacokinetic profile of CBP-1008 for Injection in patients with advanced malignant solid tumors, with expansions in selected indications.
Locations
Recruiting
Fudan University Shanghai Cancer Center
Shanghai,China
Recruiting
Cancer Hospital Chinese Academy of Medical Sciences
Beijing,China
Recruiting
Sun Yat-sen Memorial Hospital
Guangzhou,China
No longer available
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou,China
Recruiting
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine
Hangzhou,China
Recruiting
Tianjin Medical University Cancer Institute&Hospital
Tianjin,China
No longer available
The First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou,China
Recruiting
Henan Cancer Hospital
Zhengzhou,China
Recruiting
The First Affiliated Hospital of Xiamen University
Xiamen,China
No longer available
Harbin Medical University Cancer Hospital
Harbin,China
Recruiting
Hunan Cancer Hospital
Changsha,China
Recruiting
Qilu Hospital of Shandong University
Jinan,China
Recruiting
Hubei Cancer Hospital
Wuhan,China
Recruiting
Linyi Cancer Hospital
Linyi,China
No longer available
The Second Affiliated Hospital of Suzhou University
Suzhou,China
No longer available
Beijing Obstetrics and Gynecology Hospital
Beijing,China
Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan,China
Recruiting
Jilin Cancer Hospital
Jilin,China
Recruiting
Tongji Hospital of Tongji University
Shanghai,China
No longer available
The Second Affiliated Hospital of Chongqing Medical University
Chongqing,China
Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou,China
Recruiting
Zhejiang Cancer Hospital
Hangzhou,China
Recruiting